GeoVax Labs (GOVX) had the highest return between 2010 and 2013 by a US stock, returning 5,263,157,794.2%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GeoVax Labs (GOVX) | 2010-2013 | 5,263,157,794.21% |
Cenntro Electric (CENN) | 2010-2013 | 114,285,614.27% |
GT Biopharma (GTBP) | 2010-2013 | 52,699,934% |
Ascent Solar Technologies, Inc Common Stock (ASTI) | 2010-2013 | 18,552,775.69% |
Evogene (EVGN) | 2010-2013 | 7,859,900% |
Avita Medical (RCEL) | 2010-2013 | 3,199,900% |
Sequans Communications (SQNS) | 2010-2013 | 2,409,538.55% |
QXO (QXO) | 2010-2013 | 2,352,000% |
Nutex Health (NUTX) | 2010-2013 | 824,076.7% |
BTCS (BTCS) | 2010-2013 | 773,890.47% |
NextTrip (NTRP) | 2010-2013 | 493,233.33% |
Castellum (CTM) | 2010-2013 | 469,465.22% |
Prairie Operating Co Common Stock (PROP) | 2010-2013 | 132,252.95% |
Anfield Energy (AEC) | 2010-2013 | 99,583.54% |
Nixxy (NIXX) | 2010-2013 | 71,900% |
Rezolute (RZLT) | 2010-2013 | 31,076.47% |
Lipocine (LPCN) | 2010-2013 | 27,950% |
Cementos Pacasmayo SAA ADR (CPAC) | 2010-2013 | 15,519.46% |
Clearpoint Neuro (CLPT) | 2010-2013 | 7,633.33% |
Mesoblast (MESO) | 2010-2013 | 5,904.1% |
Cocrystal Pharma (COCP) | 2010-2013 | 5,674.15% |
Akari Therapeutics (AKTX) | 2010-2013 | 5,580% |
Actinium Pharmaceuticals (ATNM) | 2010-2013 | 5,254.54% |
Par Pacific (PARR) | 2010-2013 | 3,616.67% |
Xpel (XPEL) | 2010-2013 | 3,273.68% |